| Mediating
factor |
Route |
Effect
value |
95%
CI |
| Lower |
Upper |
| DP |
Exercise
intensity |
| No→DP→cognitive
decline |
Reference |
|
| Light→DP→cognitive
decline |
-0,002 |
-0,013 |
0,006 |
| Moderate→DP→cognitive
decline |
-0,004 |
-0,020 |
0,009 |
| Vigorous→DP→cognitive
decline |
-0,007 |
-0,031 |
0,015 |
| Exercise
frequency |
| No→DP→cognitive
decline |
Reference |
|
| Light,
1-5 days→DP→cognitive decline |
-0,001 |
-0,012 |
0,011 |
| Light,
6-7 days→DP→cognitive decline |
-0,002 |
-0,014 |
0,007 |
| Moderate,
1-5 days→DP→cognitive decline |
-0,004 |
-0,022 |
0,009 |
| Moderate,
6-7 days→DP→cognitive decline |
-0,004 |
-0,021 |
0,009 |
| Vigorous,
1-5 days→DP→cognitive decline |
-0,008 |
-0,037 |
0,017 |
| Vigorous,
6-7 days→DP→cognitive decline |
-0,006 |
-0,028 |
0,013 |
| PAC |
| Basic→DP→cognitive
decline |
Reference |
|
| Increased
PAC Q1→DP→cognitive decline |
-0,004 |
-0,02 |
0,008 |
| Increased
PAC Q2→DP→cognitive decline |
-0,003 |
-0,015 |
0,006 |
| Increased
PAC Q3→DP→cognitive decline |
-0,008 |
-0,03 |
0,012 |
| Increased
PAC Q4→DP→cognitive decline |
-0,007 |
-0,029 |
0,011 |
| Sleep
duration |
Exercise
intensity |
| No→sleep
duration→cognitive decline |
Reference |
|
| Light→sleep
duration→cognitive decline |
-0,003 |
-0,017 |
0,007 |
| Moderate→sleep
duration→cognitive decline |
-0,004 |
-0,019 |
0,008 |
| Vigorous→sleep
duration→cognitive decline |
-0,001 |
-0,011 |
0,006 |
| Exercise
frequency |
| No→sleep
duration→cognitive decline |
Reference |
|
| Light,
1-5 days→sleep duration→cognitive decline |
-0,008 |
-0,035 |
0,014 |
| Light,
6-7 days→sleep duration→cognitive decline |
-0,002 |
-0,013 |
0,006 |
| Moderate,
1-5 days→sleep duration→cognitive decline |
-0,002 |
-0,014 |
0,006 |
| Moderate,
6-7 days→sleep duration→cognitive decline |
-0,005 |
-0,023 |
0,009 |
| Vigorous,
1-5 days→sleep duration→cognitive decline |
-0,001 |
-0,011 |
0,006 |
| Vigorous,
6-7 days→sleep duration→cognitive decline |
-0,001 |
-0,01 |
0,006 |
| PAC |
| Basic→sleep
duration→cognitive decline |
Reference |
|
| Increased
PAC Q1→sleep duration→cognitive decline |
-0,003 |
-0,016 |
0,007 |
| Increased
PAC Q2→sleep duration→cognitive decline |
-0,003 |
-0,017 |
0,008 |
| Increased
PAC Q3→sleep duration→cognitive decline |
-0,004 |
-0,019 |
0,009 |
| Increased
PAC Q4→sleep duration→cognitive decline |
0 |
-0,008 |
0,007 |
| HbA1c |
Exercise
intensity |
| No→HbA1c→cognitive
decline |
Reference |
|
| Light→HbA1c→cognitive
decline |
-0,0012 |
-0,0139 |
0,0074 |
| Moderate→HbA1c→cognitive
decline |
0,0009 |
-0,0099 |
0,0115 |
| Vigorous→HbA1c→cognitive
decline |
-0,0017 |
-0,0143 |
0,0058 |
| Exercise
frequency |
| No→HbA1c→cognitive
decline |
Reference |
|
| Light,
1-5 days→HbA1c→cognitive decline |
0,001 |
-0,016 |
0,018 |
| Light,
6-7 days→HbA1c→cognitive decline |
-0,002 |
-0,014 |
0,007 |
| Moderate,
1-5 days→HbA1c→cognitive decline |
0,007 |
-0,005 |
0,029 |
| Moderate,
6-7 days→HbA1c→cognitive decline |
-0,002 |
-0,015 |
0,005 |
| Vigorous,
1-5 days→HbA1c→cognitive decline |
-0,001 |
-0,013 |
0,008 |
| Vigorous,
6-7 days→HbA1c→cognitive decline |
-0,002 |
-0,015 |
0,006 |
| PAC |
| Basic→HbA1c→cognitive
decline |
Reference |
|
| Increased
PAC Q1→HbA1c→cognitive decline |
0 |
-0,011 |
0,009 |
| Increased
PAC Q2→HbA1c→cognitive decline |
-0,001 |
-0,012 |
0,008 |
| Increased
PAC Q3→HbA1c→cognitive decline |
0 |
-0,01 |
0,01 |
| Increased
PAC Q4→HbA1c→cognitive decline |
-0,002 |
-0,015 |
0,006 |
| Blood
glucose |
Exercise
intensity |
| No→blood
glucose→cognitive decline |
Reference |
|
| Light→blood
glucose→cognitive decline |
-0,0024 |
-0,0161 |
0,0048 |
| Moderate→blood
glucose→cognitive decline |
-0,0022 |
-0,0145 |
0,0057 |
| Vigorous→blood
glucose→cognitive decline |
-0,0067 |
-0,0232 |
0,0022 |
| Exercise
frequency |
| No→blood
glucose→cognitive decline |
Reference |
|
| Light,
1-5 days→blood glucose→cognitive decline |
-0,001 |
-0,02 |
0,014 |
| Light,
6-7 days→blood glucose→cognitive decline |
-0,003 |
-0,016 |
0,005 |
| Moderate,
1-5 days→blood glucose→cognitive decline |
-0,005 |
-0,006 |
0,025 |
| Moderate,
6-7 days→blood glucose→cognitive decline |
-0,006 |
-0,023 |
0,002 |
| Vigorous,
1-5 days→blood glucose→cognitive decline |
-0,007 |
-0,025 |
0,003 |
| Vigorous,
6-7 days→blood glucose→cognitive decline |
-0,006 |
-0,023 |
0,003 |
| PAC |
| Basic→blood
glucose→cognitive decline |
Reference |
|
| Increased
PAC Q1→blood glucose→cognitive decline |
-0,002 |
-0,015 |
0,005 |
| Increased
PAC Q2→blood glucose→cognitive decline |
-0,004 |
-0,019 |
0,004 |
| Increased
PAC Q3→blood glucose→cognitive decline |
-0,003 |
-0,018 |
0,004 |
| Increased
PAC Q4→blood glucose→cognitive decline |
-0,006 |
-0,023 |
0,002 |
| CESD |
Exercise
intensity |
| No→cesd→cognitive
decline |
Reference |
|
| Light→cesd→cognitive
decline |
-0,007 |
-0,0235 |
0,0035 |
| Moderate→cesd→cognitive
decline |
-0,0072 |
-0,0236 |
0,0033 |
| Vigorous→cesd→cognitive
decline |
-0,0002 |
-0,0111 |
0,0107 |
| Exercise
frequency |
| No→cesd→cognitive
decline |
Reference |
|
| Light,
1-5 days→cesd→cognitive decline |
0,001 |
-0,016 |
0,02 |
| Light,
6-7 days→cesd→cognitive decline |
-0,009 |
-0,027 |
0,003 |
| Moderate,
1-5 days→cesd→cognitive decline |
-0,005 |
-0,021 |
0,006 |
| Moderate,
6-7 days→cesd→cognitive decline |
-0,009 |
-0,027 |
0,003 |
| Vigorous,
1-5 days→cesd→cognitive decline |
-0,002 |
-0,015 |
0,01 |
| Vigorous,
6-7 days→cesd→cognitive decline |
0,001 |
-0,01 |
0,014 |
| PAC |
| Basic→cesd→cognitive
decline |
Reference |
|
| Increased
PAC Q1→cesd→cognitive decline |
-0,0074 |
-0,025 |
0,003 |
| Increased
PAC Q2→cesd→cognitive decline |
-0,007 |
-0,024 |
0,003 |
| Increased
PAC Q3→cesd→cognitive decline |
-0,004 |
-0,019 |
0,005 |
| Increased
PAC Q4→cesd→cognitive decline |
0,001 |
-0,01 |
0,014 |
| Uric
acid |
Exercise
intensity |
| No→uric
acid→cognitive decline |
Reference |
|
| Light→uric
acid→cognitive decline |
0,017 |
-0,003 |
0,044 |
| Moderate→uric
acid→cognitive decline |
0,005 |
-0,004 |
0,02 |
| Vigorous→uric
acid→cognitive decline |
0,008 |
-0,003 |
0,024 |
| Exercise
frequency |
| No→uric
acid→cognitive decline |
Reference |
|
| Light,
1-5 days→uric acid→cognitive decline |
0,014 |
-0,004 |
0,047 |
| Light,
6-7 days→uric acid→cognitive decline |
0,018 |
-0,003 |
0,045 |
| Moderate,
1-5 days→uric acid→cognitive decline |
0,006 |
-0,006 |
0,022 |
| Moderate,
6-7 days→uric acid→cognitive decline |
0,005 |
-0,004 |
0,02 |
| Vigorous,
1-5 days→uric acid→cognitive decline |
0,005 |
-0,005 |
0,021 |
| Vigorous,
6-7 days→uric acid→cognitive decline |
0,01 |
-0,002 |
0,028 |
| PAC |
| Basic→uric
acid→cognitive decline |
Reference |
|
| Increased
PAC Q1→uric acid→cognitive decline |
0,016 |
-0,002 |
0,04 |
| Increased
PAC Q2→uric acid→cognitive decline |
0,011 |
-0,002 |
0,031 |
| Increased
PAC Q3→uric acid→cognitive decline |
0,008 |
-0,003 |
0,025 |
| Increased
PAC Q4→uric acid→cognitive decline |
0,005 |
-0,005 |
0,02 |
| CRP |
Exercise
intensity |
| No→CRP→cognitive
decline |
Reference |
|
| Light→CRP→cognitive
decline |
0,001 |
-0,006 |
0,009 |
| Moderate→CRP→cognitive
decline |
0,007 |
-0,006 |
0,02 |
| Vigorous→CRP→cognitive
decline |
0,0002 |
-0,006 |
0,009 |
| Exercise
frequency |
| No→CRP→cognitive
decline |
Reference |
|
| Light,
1-5 days→CRP→cognitive decline |
0,008 |
-0,009 |
0,028 |
| Light,
6-7 days→CRP→cognitive decline |
0 |
-0,007 |
0,007 |
| Moderate,
1-5 days→CRP→cognitive decline |
0,007 |
-0,005 |
0,026 |
| Moderate,
6-7 days→CRP→cognitive decline |
0,007 |
-0,006 |
0,02 |
| Vigorous,
1-5 days→CRP→cognitive decline |
0,004 |
-0,004 |
0,023 |
| Vigorous,
6-7 days→CRP→cognitive decline |
-0,003 |
-0,011 |
0,003 |
| PAC |
| Basic→CRP→cognitive
decline |
Reference |
|
| Increased
PAC Q1→CRP→cognitive decline |
0,004 |
-0,004 |
0,016 |
| Increased
PAC Q2→CRP→cognitive decline |
0,002 |
-0,005 |
0,01 |
| Increased
PAC Q3→CRP→cognitive decline |
0,005 |
-0,005 |
0,014 |
| Increased
PAC Q4→CRP→cognitive decline |
0 |
-0,006 |
0,011 |
| NHDL-C |
Exercise
intensity |
| No→NHDL-C→cognitive
decline |
Reference |
|
| Light→NHDL-C→cognitive
decline |
-0,004 |
-0,018 |
0,005 |
| Moderate→NHDL-C→cognitive
decline |
0,001 |
-0,008 |
0,012 |
| Vigorous→NHDL-C→cognitive
decline |
0,007 |
-0,005 |
0,024 |
| Exercise
frequency |
| No→NHDL-C→cognitive
decline |
Reference |
|
| Light,
1-5 days→NHDL-C→cognitive decline |
-0,003 |
-0,021 |
0,009 |
| Light,
6-7 days→NHDL-C→cognitive decline |
-0,004 |
-0,017 |
0,005 |
| Moderate,
1-5 days→NHDL-C→cognitive decline |
-0,002 |
-0,015 |
0,008 |
| Moderate,
6-7 days→NHDL-C→cognitive decline |
0,002 |
-0,006 |
0,014 |
| Vigorous,
1-5 days→NHDL-C→cognitive decline |
0,007 |
-0,006 |
0,025 |
| Vigorous,
6-7 days→NHDL-C→cognitive decline |
0,007 |
-0,006 |
0,025 |
| PAC |
| Basic→NHDL-C→cognitive
decline |
Reference |
|
| Increased
PAC Q1→NHDL-C→cognitive decline |
-0,002 |
-0,012 |
0,006 |
| Increased
PAC Q2→NHDL-C→cognitive decline |
-0,003 |
-0,017 |
0,005 |
| Increased
PAC Q3→NHDL-C→cognitive decline |
0,004 |
-0,005 |
0,019 |
| Increased
PAC Q4→NHDL-C→cognitive decline |
0,007 |
-0,007 |
0,026 |
| Triglyceride |
Exercise
intensity |
| No→triglyceride→cognitive
decline |
Reference |
|
| Light→triglyceride→cognitive
decline |
0,004 |
-0,017 |
0,022 |
| Moderate→triglyceride→cognitive
decline |
-0,001 |
-0,012 |
0,006 |
| Vigorous→triglyceride→cognitive
decline |
-0,001 |
-0,013 |
0,006 |
| Exercise
frequency |
| No→triglyceride→cognitive
decline |
Reference |
|
| Light,
1-5 days→triglyceride→cognitive decline |
0,002 |
-0,013 |
0,015 |
| Light,
6-7 days→triglyceride→cognitive decline |
0,004 |
-0,018 |
0,023 |
| Moderate,
1-5 days→triglyceride→cognitive decline |
-0,001 |
-0,01 |
0,007 |
| Moderate,
6-7 days→triglyceride→cognitive decline |
-0,001 |
-0,013 |
0,007 |
| Vigorous,
1-5 days→triglyceride→cognitive decline |
-0,001 |
-0,015 |
0,007 |
| Vigorous,
6-7 days→triglyceride→cognitive decline |
-0,001 |
-0,012 |
0,006 |
| PAC |
| Basic→triglyceride→cognitive
decline |
Reference |
|
| Increased
PAC Q1→triglyceride→cognitive decline |
0,003 |
-0,013 |
0,019 |
| Increased
PAC Q1→triglyceride→cognitive decline |
0 |
-0,009 |
0,008 |
| Increased
PAC Q3→triglyceride→cognitive decline |
-0,002 |
-0,013 |
0,006 |
| Increased
PAC Q4→triglyceride→cognitive decline |
-0,001 |
-0,013 |
0,006 |
|